1-(2-(4-ETHOXYPHENYL)ETHYNYL)-4-PROPYLBENZENE, 97%, 100g

3'-(CHLOROMETHYL)-2,6-DIMETHYL-4-(3-(METHYLSULFONYL)PROPOXY)-1,1'-BIPHENYL, 95.0%, 5g

2-(2-Methyl-piperidin-1-yl)-ethylamine, 95.0%, 1g

7-Hydroxy-3,4-Dihydro-2(1H)-quinolinone, 99.0%, 25g

tert-butyl N-methyl-N-(3-oxocyclobutyl)carbamate, 97.0%, 5g

4-Methoxy-benzothiazole-2,6-diamine, 1g

2,2'-Dinaphthyl Ether>99.0%(GC)25g

Microliter syringe GASTIGHT® series 1700 Point type 2, 10 µl, 1701 RN, 1 piece

(2-Chloro-3-(trifluoromethyl)phenyl)hydrazine hydrochloride, 5g

Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid, 95.0%, 10g

Rubidium chloride 98+% 25 g

4-(Difluoromethyl)-3-fluoropyridine, 98.0%, 250mg

4-(4-Methoxyphenyl)oxane-4-carbonitrile, 95.0%, 1g